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Summary
Ink4a/Arf inactivation and epidermal growth factor receptor (EGFR) activation are signature lesions in high-grade gliomas.
How these mutations mediate the biological features of these tumors is poorly understood. Here, we demonstrate that
combined loss of p16INK4a and p19ARF, but not of p53, p16INK4a, or p19ARF, enables astrocyte dedifferentiation in response to
EGFR activation. Moreover, transduction of Ink4a/Arf/ neural stem cells (NSCs) or astrocytes with constitutively active
EGFR induces a common high-grade glioma phenotype. These findings identify NSCs and astrocytes as equally permissive
compartments for gliomagenesis and provide evidence that p16INK4a and p19ARF synergize to maintain terminal astrocyte
differentiation. These data support the view that dysregulation of specific genetic pathways, rather than cell-of-origin,
dictates the emergence and phenotype of high-grade gliomas.
Introduction of primary GBM and the transition to secondary GBM. Indeed,
the frequent association of Ink4a/Arf loss of function and activa-
Glioblastoma (GBM), the most common and lethal subtype of tion of EGFR in GBM (Ekstrand et al., 1991; Hayashi et al.,
the malignant gliomas, is characterized by intense proliferation 1997; von Deimling et al., 1992) raises the possibility that critical
and widespread invasion of poorly differentiated cells. These functional interactions between these mutations underlie a com-
highly advanced tumors can arise de novo (primary GBM) or mon mechanism of cellular transformation. The precise contri-
evolve from a well-differentiated low-grade astrocytoma (sec- butions of these mutations to the tumor phenotype are not
ondary GBM) over a 5–10 year period (Kleihues and Cavenee, known, although immortal growth is characteristic of Ink4a/Arf
null murine astrocytes (Holland et al., 1998b) and replicative2000), suggesting that common mechanisms drive the genesis
S I G N I F I C A N C E
This work, demonstrating that both astrocytes and neural stem cells can serve as the cell-of-origin for high-grade malignant gliomas,
addresses a longstanding debate in the field of neuro-oncology and neurodevelopment. The central finding is that a combination
of EGF receptor pathway activation and loss of both p16INK4a and p19ARF tumor suppressor function provokes a common high-grade
glioma phenotype regardless of the specific cell-of-origin. Moreover, this work identifies a new function for Ink4a/Arf tumor suppressor,
and interaction with EGFR activation, in the maintenance of astrocyte terminal differentiation. Together, these findings provide insight
into the cellular origins of malignant glioma and the role of its signature genetic lesions in the pathogenesis of these highly lethal
brain cancers.
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Figure 1. Comparison of Ink4a/Arf/ and /
NSCs and astrocytes
A: NSC morphology (upper panels) and nestin
staining (inset upper panels) of neurospheres is
similar for Ink4a/Arf/ and / cultures. Astrocyte
morphology (lower panels) and GFAP staining
(inset lower panels) is also similar between Ink4a/
Arf/ and / cultures. B: The total number of
EGF responsive NSCs isolated from Ink4a/Arf/
and / brains at E8.5 (n  4), E10.5 (n  9), E13.5
(n  38), E17.5 (n  12), P1 (n  16), and adult
(6 weeks, n  4). C: The total number of neu-
rospheres generated in defined media with EGF
(20 ng/ml), without EGF, and with PDGF (50 ng/
ml). Data represent the means  the standard
error of the mean (SEM) of the number of stem
cells residing in the striatal germinal zone at E13.5
(n 32–38 embryos per genotype). D: Differenti-
ation of Ink4a/Arf/ NSCs (nestin positive) into
astrocytes (GFAP positive, lower left) in response
to serum and neurons (TUJ1, lower right) in re-
sponse to BDNF.
senescence can be elicited upon p16INK4a reintroduction into type-B cells of the subventricular zone in vivo (Doetsch et al.,
1999), and cells expressing immature markers have been de-human malignant glioma cells (Uhrbom et al., 1997).
Previous work has indicated that delivery of activated EGFR rived from the GFAP-expressing compartment in vitro (Holland
et al., 1998b). Thus, the possible evolution of glioma from theinto the brains of newborn Ink4a/Arf/ mice can induce glial
tumors more readily when targeted to the nestin-expressing mature astrocytic cell, as opposed to a GFAP-positive immature
compartment, remains unclear in available genetic model sys-rather than the GFAP-expressing compartment (Holland et al.,
1998a). Because both NSCs and early astroglial progenitors tems. Through the use of rigorously defined primary NSC and
mature astrocyte cultures, the present study sought to de-express nestin, it has been proposed that this less mature com-
partment may provide a more permissive state for the trans- termine whether the specific state of glial cell differentiation
plays a restrictive role in glioma progression or, alternatively,forming effects of EGFR pathway activation. Moreover, the
GFAP regulatory element can drive expression into multipotent whether glioma relevant mutations can alter the state of differen-
Figure 2. p16INK4a and p19ARF cooperate to regu-
late the growth of astrocytes but not NSCs
Growth during serial passage by Ink4a/Arf geno-
type for NSCs (A) and astrocytes (B). C: Number
of persistently growing astrocyte lines (i.e., “non-
senesced” [Sharpless et al., 2001]) by passage
and p16INK4a and p19ARF status. D: Western blot
analysis of p16INK4a and p19ARF in NSCs and
astrocytes by Ink4a/Arf genotype. Control 
p16INK4a and p19ARF overexpressing tumor cell line.
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Figure 3. Ink4a/Arf/ astrocytes dedifferentiate
to nestin, A2B5 progenitor cells in vitro
Ink4a/Arf/ (A) and / (B) cells were removed
from serum and grown in EGF on day 0. Ink4a/
Arf/ cells rapidly change morphology and re-
sulting bipolar cells and neurospheres are nestin
and A2B5 (double labeling inset, far right panel
of B), whereas Ink4a/Arf/ cells do not dediffer-
entiate and remain GFAP (inset, far right panel
of A). Western blot analysis of cultured astrocytes
of indicated genotypes after treatment with
EGF. Equivalent MAPK and AKT (C), and EGFR
(D), phosphorylation is seen in Ink4a/Arf/ and
/ cells after EGF exposure.
tiation and dictate the tumor phenotype regardless of the cell- ate into GFAP-positive astrocytes (93 4%) and TUJ1-positive
neurons (40 5%) in response to serum and BDNF, respectivelyof-origin.
(Figure 1D).
The established cell-type specific roles of p16INK4a and p19ARFResults
in cellular growth control (Kamijo et al., 1999; Randle et al.,
2001; Sharpless et al., 2001) prompted a detailed proliferationPrevious gross and histological analyses of Ink4a/Arf/ mice
are consistent with normal central nervous system structure analysis of early passage NSC and astrocyte cultures. Although
Ink4a/Arf/ and / NSCs (Figure 2A) exhibited comparableand function (Serrano et al., 1996 and R.M.B. and R.A.D., unpub-
lished). In this study, the dispensability of p16INK4a and p19ARF growth rates, there was a striking increase in the proliferative
rate of Ink4a/Arf/ astrocytes relative to wild-type cultures (Fig-function in brain development was confirmed by an extensive
histological and morphometric analysis of the developing brain ure 2B). Correspondingly, cell cycle analysis of early passage
astrocyte cultures showed marked differences in the S phasefrom Ink4a/Arf/ mutants and control littermates on embryonic
days E13.5, E15.5, and E19, postnatal days 1 and 25, and aging fraction (33% for Ink4a/Arf/ versus 12% for / astrocytes,
n  5 cultures each, p  0.005). As shown previously for oligo-adults (data not shown). These studies were complemented
by a series of cell culture-based analyses of the growth and dendrocyte precursors (Tang et al., 2001), Ink4a/Arf/ NSCs
proliferated indefinitely if prevented from differentiating. In con-differentiation of NSCs and cortical astrocytes. The various
Ink4a/Arf genotypes exhibited similar morphology and differenti- trast, serially passaged Ink4a/Arf/ astrocytes exhibited im-
mortal growth, while Ink4a/Arf/ astrocytes, as well as thoseation markers of primary NSC and astrocyte cultures (Figure
1A) and showed comparable emergence of an EGF-responsive specifically deficient for p16INK4a (Sharpless et al., 2001) or p19ARF
(N.E.S. and R.A.D., unpublished data), underwent proliferativeNSC pool on E10.5, with expansion through E13.5 (Figure 1B)—
kinetics that reflect the increased EGF responsiveness during arrest and assumed senescent features by 5 to 7 population
doublings (Figure 2C). p19ARF/, but not p16INK4a/ or Ink4a/development (Chiasson et al., 1999; Qian et al., 2000). Similar
to littermate wild-type cultures, Ink4a/Arf/NSCs retained strict Arf/, cultures exhibited a moderate rate of escape from senes-
cence (2 of 7 cultures, Figure 2C), while 100% of Ink4a/Arf/EGF dependence for growth, and PDGF substitution was unable
to sustain wild-type or mutant cultures (Figure 1C). Moreover, cultures were immortal. Consistent with these observed devel-
opmental stage-specific differences in cell growth control,Ink4a/Arf status did not affect the capacity of NSCs to differenti-
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Figure 4. p53/, p16INK4a/, and p19ARF/
astrocytes do not dedifferentiate in response to
EGF
Cultures were grown in serum-free media supple-
mented with EGF (20 ng/ml) for 10 days. A: In
contrast to Ink4a/Arf/ astrocytes, p53/,
p16INK4a/, and p19ARF/ astrocytes did not
change morphology in response to EGF and re-
mained GFAP and nestin (insets represent
double labeling with GFAP [red] and nestin
[green] [n  4 independently derived cell lines
for each genotype]). B: Ink4a/Arf/ astrocytes
expressing the wild-type EGFR do not dedifferen-
tiate in serum-free media lacking EGF. C: Ink4a/
Arf/ astrocytes expressing EGFR* dedifferenti-
ate in serum-free media lacking EGF. D: Ink4a/
Arf/ astrocytes expressing EGFR* do not dedif-
ferentiate. E: EGFR* expression in NSCs can substi-
tute for ligand. Ink4a/Arf/ EGFR* NSC cultures
were grown in serum free media without EGF.
Ink4a/Arf/ cultures transduced with the wild-
type EGFR do not proliferate under these condi-
tions, but rather undergo apoptosis (not shown).
p16INK4a and p19ARF were undetectable in extensively passaged nestin and A2B5 (Figure 3B, inset). As added confirmation of the
wild-type NSC cultures, whereas both p16INK4a and p19ARF were immature state, dedifferentiated cultures rapidly redifferentiated
readily detected in cultured Ink4a/Arf/ astrocytes (Figure 2D). into GFAP positive astrocytes when reexposed to serum. In
Taken together, these data demonstrate that both p16INK4a and a small minority of cultures, TUJ1 positive neurons could be
p19ARF play important, yet developmentally restricted, roles in generated from the dedifferentiated astrocytes upon exposure
the control of astroglial lineage proliferation in vitro. to BDNF (data not shown). These Ink4a/Arf-dependent re-
The transition to a poorly differentiated glial phenotype in sponses were not related to differences in EGFR expression
progression from low-grade astrocytoma to secondary GBM or activation, as evidenced by a comparable degree of EGF-
prompted an assessment of Ink4a/Arf and the EGFR pathway induced EGFR phosphorylation (Figure 3D) and activation of
interactions in the maintenance of astrocyte differentiation. Sub- the EGFR signaling surrogates, MAPK and AKT (Figure 3C). To
confluent cycling early passage GFAP primary astrocytes were understand further these synergistic actions, we asked whether
removed from serum-supplemented media and exposed to se- immortalization per se or the capacity for rapid proliferation
rum-free media containing EGF (20 ng/ml). Under these condi- represent the key parameters that endow EGF-induced
tions, all Ink4a/Arf/ cultures as well as astrocyte cultures de- astrocyte plasticity. Despite rapid rates of growth and an immor-
rived from p16INK4a null and p19ARF null mice survived, continued tal phenotype, p53/ astrocyte cultures subjected to prolonged
to proliferate, and retained the morphological and immunohisto- EGF treatment failed to induce morphological or immunohisto-
chemical features of fully differentiated astrocytes (Figure 3A). chemical changes consistent with dedifferentiation (Figure 4A).
In sharp contrast, EGF-treated Ink4a/Arf/ astrocytes en masse Likewise, astrocytes from mice singly deficient for either p16INK4a
showed contracted cytoplasm within 24 hr and, over the course or p19ARF did not dedifferentiate in response to EGF (Figure 4A).
of 7 to 10 days, developed into bipolar cells coexisting with Furthermore, in contrast to a previous report showing PDGF
small neurospheres which detached from the culture dish and induction of glial progenitor morphology and expression mark-
continued to proliferate as substrate-independent neurospheres ers in wild-type astrocytes after extended passage in culture
(Figure 3B)—properties ascribed to NSCs. While littermate wild- (40 days) (Dai et al., 2001), the placement of early-passage
type astrocyte cultures retained GFAP expression in EGF (Figure Ink4a/Arf/, p53/, or Ink4a/Arf/ astrocyte cultures in serum-
3A, inset), Ink4a/Arf/ cultures demonstrated synchronous free media containing 50 ng/ml PDGF did not induce dedifferen-
complete loss of GFAP and induction of the progenitor markers tiation (data not shown); see Discussion.
To determine whether cell-autonomous effects of this gli-
oma-relevant lesion could induce astrocyte dedifferentiation in
vitro, Ink4a/Arf/ and / astrocytes were inoculated with retro-
Table 1. Growth of orthotopically transplanted astrocytes and NSCs in SCID virus encoding EGFR* or wild-type EGFR (EGFR-WT) in serum-
brains
free media with EGF supplementation. Comparable expression
Transduced with: of transduced EGFR* and EGFR-WT protein was documented
EGFR WT EGFR* by Western blot analysis (not shown). Both EGFR* and EGFR-
WT Ink4a/Arf/ astrocytes recapitulated the aforementionedInk4a/arf/ Astrocytes 0/4 0/4
Ink4a/arf/ Astrocytes 0/4 4/4 dedifferentiation response (n  4 cultures each), although this
Ink4a/arf/ NSCs 0/6 0/6 response required EGF supplementation in the case of EGFR-
Ink4a/arf/ NSCs 0/6 6/6 WT Ink4a/Arf/ cultures (Figures 4B and 4C). EGF and EGFR*
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Figure 5. Expression of EGFR* in Ink4a/Arf/ NSCs and astrocytes induces high-grade gliomas
Tumors derived from Ink4a/Arf/ EGFR* NSCs and astrocytes orthotopically transplanted into the brain are gadolinium enhancing on MRI, grow as poorly
differentiated high-grade tumors (H&E 10 and 40), and express GFAP, Nestin, and Olig2.
induced dedifferentiation responses were similar, except that shown). Moreover, it is highly unlikely that such astrocyte cul-
tures would be contaminated with NSCs since primary culturesthe kinetics of dedifferentiation were faster in response to EGF
(average of 8.5 versus 18 days, n  6 cultures each)—a finding were derived from P5 cortex, which lacks immature cells. Neither
Ink4a/Arf/NSCs nor astrocytes yielded tumors or neurologicalconsistent with a more modest activation of MAPK activation
by EGFR*. Of note, despite robust and comparable levels of deficits after 3 months, even when engineered to express EGFR*
(or EGFR-WT) (Table 1). In contrast, EGFR* Ink4a/Arf/ NSCtransduced EGFR* or EGFR-WT and activation of MAPK in EGF,
Ink4a/Arf/ cultures did not dedifferentiate under any condi- and astrocyte cultures readily formed tumors with a latency of
4–8 weeks (Figure 5). Clonality of these tumors was confirmedtions (Figure 4D, n 4 cultures each). That EGFR* was function-
ally activated was documented further by the survival of dediffer- by the emergence of a distinct banding pattern on Southern
blots assayed for hybridization to a Moloney LTR fragment whenentiated Ink4a/Arf/ EGFR* cultures and Ink4a/Arf/ EGFR*
NSCs in the absence of EGF supplementation (Figure 4E). The compared to parental cell lines (data not shown). The tumori-
genic competence of EGFR* Ink4a/Arf/ NSCs and astrocytes,findings corroborate the EGF ligand studies and raise the possi-
bility that these key glioma lesions may drive the classical poorly as opposed to EGFR* Ink4a/Arf/ controls, was documented
further by tumor formation following subcutaneous injectionsdifferentiated glial phenotype of these cancers.
The genetically defined primary cultures described in this into SCID mice (Figure 6B).
Notably, despite being at opposite ends of the differentiationstudy provided an opportunity to assess directly how the state
of astroglial differentiation influences the transforming actions spectrum, both EGFR* Ink4a/Arf/NSCs and astrocytes (Figure
5) yielded neoplasms with overlapping clinical, radiographic,of EGFR* in vivo. To this end, early passage EGFR* or EGFR-
WT transduced NSCs (2104 cells per injection, n  6 per and histopathological features. Clinically, all animals presented
with focal neurological signs that included asymmetric hindlimbgenotype) and astrocytes (2104 cells per injection, n  4 per
genotype) from Ink4a/Arf/ and / mice were transplanted and forelimb dystonia followed by progressive paraplegia.
These symptoms matched precisely MRI findings of gadoliniumorthotopically into the brains of adult SCID mice and followed
for 12 weeks or until development of focal neurological deficits enhancing mass lesions in the striatum and did not reflect neuro-
logical trauma associated with the injection (Figure 5). Histologi-(Table 1). Astrocyte cultures were maintained in serum prior to
injection to avoid the possibility that tumor formation was a cally, the tumors from both EGFR* Ink4a/Arf/ NSCs and
astrocytes resembled high-grade gliomas demonstrating hyper-result of in vitro dedifferentiation. Cultures grown for 10 days
or more in serum-containing medium did not show any evidence cellularity, pleomorphism, high mitotic activity, and focal inva-
sion into normal parenchyma. Five tumors derived from NSCsof dedifferentiation either morphologically or immunohisto-
chemically, regardless of EGFR and Ink4a/Arf status. Specifi- and 3 tumors derived from astrocytes were composed of small,
undifferentiated cells (Figure 5), while 1 tumor derived fromcally, cultures showed GFAP immunoreactivity but remained
negative for the early glial markers, nestin and A2B5 (data not NSCs was composed of spindle-shaped cells and 1 tumor de-
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Figure 6. “Multiforme” nature of tumor cells and immunoreactivity for oligodendroglial and neuronal markers suggest dedifferentiation of astrocytes to a
multipotent progenitor
A: Spindle-cell and epithelioid-cell morphology was seen in 1 tumor each derived from NSCs and astrocytes. All tumors demonstrated strong hEGFR* staining
and were Sox10 positive. B: Subcutaneous tumors derived from Ink4a/Arf/ astrocytes transduced with EGFR* were high grade, poorly differentiated GFAP,
nestin, and Olig2 tumors, similar to intracranially generated tumors. In addition, rare TUJ1 staining was observed. Similar histology and immunoreactivity to
GFAP, nestin, and Olig2 were found in subcutaneous tumors derived from Ink4a/Arf/ NSCs transduced with EGFR* (not shown).
rived from astrocytes was composed of epithelioid cells (Figure tended into the surrounding neuropil in a diffuse manner. In
addition, there was conspicuous growth along white matter6A). This range of cellular morphologies is consistent with the
“multiforme” nature of human high-grade gliomas. Further evi- tracts, a pattern of spread that is typical of human gliomas.
Moreover, clusters of GFAP positive tumor cells were identifieddence for a heterogeneous composition of glial tumors was
provided by immunohistochemical analysis. EGFR*-transduced in the subarachnoid space (Figure 7; lower right panel, yellow
bar), further confirming that the GFAP positivity reflects expres-NSCs or astrocytes yielded tumors that were GFAP positive
(Figure 5). In addition, we observed that all tumors expressed sion of GFAP by tumor cells rather than background neuropil.
the immature marker nestin as well as Olig2 (Figure 5), a marker Tumor cells stained positively with nestin- and Olig2 (Lu et al.,
of oligodendroglial progenitors during normal development that 2001; Marie et al., 2001), with nestin positivity displayed as
is also expressed in human gliomas (Lu et al., 2001; Marie et elongated cellular processes seen characteristically in human
al., 2001). Sox10 positive cells were components of the tumors gliomas (Figure 7). Notably, the lesions induced in this model
(Figure 6A), further emphasizing the oligodendroglial composi- were cytologically and immunohistochemically similar to the
tion (Zhou et al., 2000). Finally, occasional cells staining with tumors generated by orthotopic transplantation of astrocytes
the immature neuronal marker, TUJ1, were observed in the and NSCs. Moreover, EGF infusion in either p16INK4a or p19ARF
subcutaneous tumors derived from astrocytes (Figure 6B). alone induced a proliferative response of similar magnitude and
These findings demonstrate that tumor cells derived from ma- degree of invasion as seen in Ink4a/Arf/brain (data not shown),
ture Ink4a/Arf deficient astrocytes can give rise to cells of the demonstrating cooperativity between p16INK4a and p19ARF in this
oligodendroglial and, rarely, neuronal lineage, thus providing process. Together, these in vivo data serve to validate the geno-
strong evidence that astrocytes dedifferentiated during tumori- typic-phenotypic correlates established in the cell culture based
genesis. studies.
To provide in vivo confirmation of the functional interrelation-
ship between EGFR activation and the status of Ink4a/Arf, Ink4a/ Discussion
Arf / and / adult mice underwent intraventricular infusion
of EGF for 7 days. In the setting of Ink4a/Arf deficiency, EGF We have demonstrated that NSCs and astrocytes can serve
equally as the glioma cell-of-origin in the setting of Ink4a/Arfinfusion induced a marked increase in proliferation (Ki-67 
10%) and diffuse infiltration of a population of GFAP immunore- deficiency and constitutive EGFR activation. These data extend
previous findings by clearly identifying the gliomagenic potentialactive cells (Figure 7). These small cells with hyperchromatic
nuclei formed a multilayered cuff around the ventricle and ex- of these two rigorously defined compartments. However, with
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The present study clearly demonstrates that astrocytes un-
dergo dedifferentiation to a multipotent progenitor cell during
tumorigenesis, a response directly resulting from the coopera-
tion between Ink4a/Arf deficiency and EGF signaling. Since nei-
ther p16INK4a nor p19ARF loss alone induced astrocyte immortali-
zation or dedifferentiation in response to EGF in vitro, our data
demonstrate a role for both proteins encoded by the Ink4a/
Arf locus in gliomagenesis and are consistent with the dual
inactivation of p16INK4a and p14ARF in 50%–70% of human high-
grade gliomas (James et al., 1988; Labuhn et al., 2001). Although
the status of the p14ARF-p53 pathway is often not known in such
cases, point mutations and promoter methylation affecting only
p16INK4a have been documented (Costello et al., 1996; Herman
et al., 1995). Likewise, an inherited germline mutation affecting
p14ARF but not p16INK4a has been associated with familial astrocy-
toma (Randerson-Moor et al., 2001), and mice lacking only
p19ARF with intact p16INK4a develop spontaneous gliomas (Kamijo
et al., 1997). These data are consistent with our observations
and suggest that both p16INK4a and p14ARF play independent roles
in suppressing glial tumor formation in humans.
How these pathways interact to maintain an astrocyte in a
terminally differentiated state is unclear. The increase in
astrocyte proliferation in response to loss of both proteins is
not sufficient for dedifferentiation, since neither Ink4a/Arf/
astrocytes in serum nor p53/ astrocytes in EGF dedifferenti-
ate. Although there is no evidence that p16INK4a and p14ARF are
involved in maintaining astrocytes in a fully differentiated state
in the normal brain, it is tempting to speculate that they may
become important in regulating the response to oncogenic stim-
uli, such as EGFR activation. Indeed, the generation of poorly
differentiated tumors from Ink4a/Arf deficient astrocytes ex-
pressing EGFR* supports an important role for p16INK4a and
p19ARF in constraining dedifferentiation. The identification of both
Sox10, an oligodendroglial marker (Zhou et al., 2000), and
GFAP, an astrocyte marker, in the tumors is evidence for mixed
glial composition, suggesting that the extent of astrocyte dedif-
ferentiation was significant, to a cell with at least a bipotent
state. The identification of rare TUJ1 positive cells suggests
that dedifferentiation may be so complete as to generate a
pluripotent cell with the potential to make neurons as well as
glia. These data are highly consistent with human high-grade
gliomas that similarly have a mixed GFAP and Olig2 staining
pattern (Lu et al., 2001). Furthermore, the identification of humanFigure 7. EGF infusion induces a marked increase in proliferation of poorly
tumors with mixed oligodendroglial and astrocytic features maydifferentiated GFAP, Nestin, and Olig2 positive cells in the subventricular
zone reflect the dynamic state between a fully dedifferentiated cell
and the commitment to astrocyte and oligodendrocyte lineages.Low and high power H&E, Ki-67, GFAP, Nestin, and Olig2 staining of Ink4a/
Arf / (A) and / (B) mice after 7 days of intraventricular EGF infusion. It is highly unlikely that expression of these lineage-restricted
Yellow bracket (bottom right panel) indicates growth of tumor cells in the markers, especially 2 markers of oligodendrocyte development,
subarachnoid space.
simply represents aberrant gene expression in cultured
astrocytes, since the same marker expression pattern was ob-
served in tumors derived from cultured NSCs. Furthermore,
lesions with similar histopathologic and immunohistochemicalregard to previous studies, it is worth noting that GFAP, although
characteristics were generated by the intraventricular infusionan established astrocyte marker, has also been shown to be
of EGF in Ink4a/Arf deficient mice. Additional markers for glialpresent in pluripotent stem cells of the subventricular zone and
tumor characterization may emerge from a more thorough un-present in the early astrocytic progenitors (Doetsch et al., 1999;
derstanding of glial ontogeny. Moreover, identification of regula-Malatesta et al., 2000). Thus, the overlapping specificities of
tory elements from such markers may provide a means to spe-GFAP and nestin in developing glia have made challenging the
cifically target subpopulations of tumor cells in vivo.investigational efforts to identify the glioma cell-of-origin, and
It is worth noting that the genetic patterns observed in hu-the identification of glial-specific promoters remains an impor-
man tumors are consistent with the biological impact docu-tant unmet need for modeling of gliomagenesis in a lineage-
restricted fashion in vivo. mented in this study. Specifically, the cooperation between
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hEGFR (H. Nakagawa, Univ. of Pennsylvania), respectively, and inserted intoInk4a/Arf deficiency and EGFR overexpression in processes of
the BamHI-NotI sites.dedifferentiation and generation of high-grade gliomas matches
well with the high frequency of these lesions in GBM (Ekstrand
Production of retrovirus stock
et al., 1991). In contrast, lack of dedifferentiation of p53 deficient 293T cells (4–6  106 ) were plated onto 10 cm dishes 14–18 hr before the
astrocytes when stimulated by EGF or PDGF in defined media transfection. Transfection by Lipofectamine Plus (Invitrogen) was performed
according to the manufacturer’s protocol. The retroviral supernatant wasis consistent with the finding that p53 deficient low-grade astro-
harvested 36–48 hr posttransfection and used to infect target cells. Inocu-cytomas maintain a well differentiated morphology and remain
lated cells were selected with 2 g/ml Puromycin for 4 days.GFAP positive and Olig2 negative (Lu et al., 2001). Moreover,
these data reinforce the view of the specific and cooperative
Stereotactic injection of cell lines
nature of the interactions between the EGFR pathway and Ink4a/ Cells for injection were suspended in Hanks Buffered Salt Solution (10,000
Arf function in processes of astrocyte dedifferentiation. cells/ul) and placed on ice. Six week old SCID mice were anesthetized with
ketamine (60 mg/kg) and xylazine (7.5 mg/kg) and placed in the stereotacticTogether, these observations provide insights into the ori-
frame using ear bars. A hole was bored in the skull 0.5 mm anterior and 3.0gins, evolution, and pathophysiology of GBM and into the roles
mm lateral to the Bregma. Two l of the cell suspension was injected intoand interactions of three signature lesions, EGFR activation and
the right caudate nucleus 3–5 mm below the surface of the brain using a
loss of p16INK4a and p14ARF. The data presented here serve to 26 gauge needle. The scalp was closed with 5.0 silk suture. Animals were
reconcile the seemingly distinct cellular origins of these tumors followed daily for development of neurological deficits.
by providing evidence that the biological behavior of the high-
Magnetic resonance imaginggrade gliomas depends not on the glial state of differentiation,
Mice with neurological deficits were anesthetized with ketamine and xylazine,but rather on the dysregulation of specific genetic elements.
as above. MR imaging was performed with a 1.5-T superconducting magnet
(Signa 5.0; GE Medical Systems, Milwaukee, WI) by using a 1.5-inch surfaceExperimental procedures
coil. Conventional T1-weighted (300/11, repetition time msec/echo time
msec), T2-weighted (2,000/102) spin-echo images were obtained in axial,Morphometric analysis of cerebral cortex and cell counts
coronal, and sagittal directions. The section thickness was 1.5 mm, with aFive coronal brain sections per animal were evaluated at 500 m intervals
field of view of 6 cm2, a 256  256 matrix, yielding a spatial resolution offrom 0.5 to 2.00 with respect to Bregma according to a stereotaxis atlas
2342341500 microns. Gd-DTPA (Magnevist: Gadopentetate dimeglu-of the mouse brain (Franklin and Paxinos, 1997). The thickness of the S2
mine, Shering, Berlin, Germany) enhanced T1-weighted images were ob-somatosensory cortex as well as the horizontal distance from left to right
tained 5 min after tail vein injection of 10 l of Magnevist.corpus callosum at mid dorsal to ventral level were measured. To estimate
the number of astrocytes in the brain, GFAP positive cells were counted in
Brain sectioning, pathological analysis, andevery tenth section (5 m) under a 20 objective. For the cerebral cortex,
immunohistochemistrythe regions containing motor and somatosensory cortex were chosen; for
For pathological analysis, brains were fixed in 10% formaldehyde for 12 hrthe hippocampus, the number of GFAP positive cells under 20 in an area
and processed for hematoxylin and eosin (H&E) by standard techniques.covering the CA1 and the dentate gyrus was chosen.
The entire brain was sectioned in 1–2 mm coronal blocks and submitted in
one cassette for paraffin embedding to facilitate analysis of the whole brain.NSC and astrocyte culture techniques
For immunohistochemical analysis, sections were prepared for staining with
Primary NSCs were isolated from the brain subventricular zone of E13.5
nestin (Pharmingen), GFAP (DAKO), Olig2 (Takebayashi), and Sox10 (Row-
embryos as described (Reynolds and Weiss, 1992). Single cells were cultured
itch) by standard techniques. For immunohistochemical analysis of cells in
in DMEM/F12 containing insulin/transferrin (Gibco), Penicillin/Streptomycin
culture, cells were fixed in 4% paraformaldehyde for 1 hr at 4	 and stained
(Gibco), and EGF (Gibco, 20 ng/ml). Primary neurospheres were passaged
with nestin, GFAP, and A2B5 (Chemicon) according to standard protocols.
by dissociation of the spheres into single cells using trituration through
a fire polished pipette. Neurospheres were differentiated into secondary
Western blotting
astrocytes by growth in 10% FBS in the media and into neurons by growth Protein lysates from NSCs and astrocytes (1–2  106 ) were prepared as
in defined media containing brain derived growth factor (BDNF, 50 ng/ml) previously described (Sharpless et al., 2001). 40 g of lysate were resolved
(Reynolds and Weiss, 1996). Primary astrocytes were isolated from 5 day on 4%–12% polyacrylamide gels (Novex) in MOPS buffer. Membranes were
old pups and prepared according to published methods (McCarthy and de blotted for p16INK4a, p19ARF, tubulin as described (Sharpless et al., 2001).
Vellis, 1980). Cells were maintained in DMEM containing 10% FBS (GIBCO). Other antibodies used (Santa Cruz) included EGFR, EGFR-phospho, Akt,
In serial passage experiments of astrocytes and NSCs, cells were seeded phospho-Akt, MAPK, and phospho MAPK at dilutions recommended by
at 900,000 cells per dish in 10 cm plates, and then split, counted, and manufacturers.
reseeded every 5 days. Population doubling per passage was determined
as log2 (cells counted after 5 days in culture/cells seeded). Both primary and Implantation of miniosmotic pumps into mouse brain
secondary astrocytes were analyzed for immortalization and dedifferentia- EGF was unilaterally infused directly into the lateral ventricles (coordinates
tion, but no difference was noted between cells from either source, and 4.0 mm anterior to the lambda suture, 0.7 mm lateral of midline, and 2.5
results were pooled in this analysis. The time course of dedifferentiation was mm below the dura) using a miniosmotic pump (Model #1007, Alza, Palo
determined by measuring the progressive change in morphology of the Alto, CA) attached to a 30 gauge cannula. EGF was infused for 7 consecutive
cells from flat polygonal cells to final culture containing bipolar cells and days at a flow rate of 0.5 l/hr with an initial pump concentration of 33 g/
neurospheres. Six independently derived cultures of each genotype were ml in 0.9% saline containing 1 mg/ml mouse serum albumin (Sigma, St.
studied in the dedifferentiation experiments. Louis, MO).
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